Liberia
IAVI vaccinates first participants in Phase I Lassa fever vaccine trial
The trial will assess the safety, tolerability, and potential of the vaccine to induce an immune response against Lassa fever.
The trial will assess the safety, tolerability, and potential of the vaccine to induce an immune response against Lassa fever.